Literature DB >> 26241000

Common Genetic Variants Influence Circulating Vitamin D Levels in Inflammatory Bowel Diseases.

Ashwin N Ananthakrishnan1, Andrew Cagan, Tianxi Cai, Vivian S Gainer, Stanley Y Shaw, Susanne Churchill, Elizabeth W Karlson, Shawn N Murphy, Isaac Kohane, Katherine P Liao, Ramnik J Xavier.   

Abstract

BACKGROUND: The accuracy and utility of electronic health record (EHR)-derived phenotypes in replicating genotype-phenotype relationships have been infrequently examined. Low circulating vitamin D levels are associated with severe outcomes in inflammatory bowel disease (IBD); however, the genetic basis for vitamin D insufficiency in this population has not been examined previously.
METHODS: We compared the accuracy of physician-assigned phenotypes in a large prospective IBD registry to that identified by an EHR algorithm incorporating codified and structured data. Genotyping for IBD risk alleles was performed on the Immunochip and a genetic risk score calculated and compared between EHR-defined patients and those in the registry. Additionally, 4 vitamin D risk alleles were genotyped and serum 25-hydroxy vitamin D [25(OH)D] levels compared across genotypes.
RESULTS: A total of 1131 patients captured by our EHR algorithm were also included in our prospective registry (656 Crohn's disease, 475 ulcerative colitis). The overall genetic risk score for Crohn's disease (P = 0.13) and ulcerative colitis (P = 0.32) was similar between EHR-defined patients and a prospective registry. Three of the 4 vitamin D risk alleles were associated with low vitamin D levels in patients with IBD and contributed an additional 3% of the variance explained. Vitamin D genetic risk score did not predict normalization of vitamin D levels.
CONCLUSIONS: EHR cohorts form valuable data sources for examining genotype-phenotype relationships. Vitamin D risk alleles explain 3% of the variance in vitamin D levels in patients with IBD.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26241000      PMCID: PMC4615315          DOI: 10.1097/MIB.0000000000000524

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  46 in total

1.  Use of a novel vitamin D bioavailability test demonstrates that vitamin D absorption is decreased in patients with quiescent Crohn's disease.

Authors:  F A Farraye; H Nimitphong; A Stucchi; K Dendrinos; A B Boulanger; A Vijjeswarapu; A Tanennbaum; R Biancuzzo; T C Chen; M F Holick
Journal:  Inflamm Bowel Dis       Date:  2011-01-06       Impact factor: 5.325

2.  Improving case definition of Crohn's disease and ulcerative colitis in electronic medical records using natural language processing: a novel informatics approach.

Authors:  Ashwin N Ananthakrishnan; Tianxi Cai; Guergana Savova; Su-Chun Cheng; Pei Chen; Raul Guzman Perez; Vivian S Gainer; Shawn N Murphy; Peter Szolovits; Zongqi Xia; Stanley Shaw; Susanne Churchill; Elizabeth W Karlson; Isaac Kohane; Robert M Plenge; Katherine P Liao
Journal:  Inflamm Bowel Dis       Date:  2013-06       Impact factor: 5.325

Review 3.  Review article: vitamin D and inflammatory bowel disease--established concepts and future directions.

Authors:  M Garg; J S Lubel; M P Sparrow; S G Holt; P R Gibson
Journal:  Aliment Pharmacol Ther       Date:  2012-06-12       Impact factor: 8.171

Review 4.  Mounting evidence for vitamin D as an environmental factor affecting autoimmune disease prevalence.

Authors:  Margherita T Cantorna; Brett D Mahon
Journal:  Exp Biol Med (Maywood)       Date:  2004-12

Review 5.  Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system.

Authors:  Margherita T Cantorna; Yan Zhu; Monica Froicu; Anja Wittke
Journal:  Am J Clin Nutr       Date:  2004-12       Impact factor: 7.045

6.  PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene-disease associations.

Authors:  Joshua C Denny; Marylyn D Ritchie; Melissa A Basford; Jill M Pulley; Lisa Bastarache; Kristin Brown-Gentry; Deede Wang; Dan R Masys; Dan M Roden; Dana C Crawford
Journal:  Bioinformatics       Date:  2010-03-24       Impact factor: 6.937

7.  Clinical trial: vitamin D3 treatment in Crohn's disease - a randomized double-blind placebo-controlled study.

Authors:  S P Jørgensen; J Agnholt; H Glerup; S Lyhne; G E Villadsen; C L Hvas; L E Bartels; J Kelsen; L A Christensen; J F Dahlerup
Journal:  Aliment Pharmacol Ther       Date:  2010-05-11       Impact factor: 8.171

8.  Biobanks and electronic medical records: enabling cost-effective research.

Authors:  Erica Bowton; Julie R Field; Sunny Wang; Jonathan S Schildcrout; Sara L Van Driest; Jessica T Delaney; James Cowan; Peter Weeke; Jonathan D Mosley; Quinn S Wells; Jason H Karnes; Christian Shaffer; Josh F Peterson; Joshua C Denny; Dan M Roden; Jill M Pulley
Journal:  Sci Transl Med       Date:  2014-04-30       Impact factor: 17.956

Review 9.  eMERGEing progress in genomics-the first seven years.

Authors:  Dana C Crawford; David R Crosslin; Gerard Tromp; Iftikhar J Kullo; Helena Kuivaniemi; M Geoffrey Hayes; Joshua C Denny; William S Bush; Jonathan L Haines; Dan M Roden; Catherine A McCarty; Gail P Jarvik; Marylyn D Ritchie
Journal:  Front Genet       Date:  2014-06-17       Impact factor: 4.599

10.  Automated extraction of clinical traits of multiple sclerosis in electronic medical records.

Authors:  Mary F Davis; Subramaniam Sriram; William S Bush; Joshua C Denny; Jonathan L Haines
Journal:  J Am Med Inform Assoc       Date:  2013-10-22       Impact factor: 4.497

View more
  11 in total

1.  Incorporating natural language processing to improve classification of axial spondyloarthritis using electronic health records.

Authors:  Sizheng Steven Zhao; Chuan Hong; Tianrun Cai; Chang Xu; Jie Huang; Joerg Ermann; Nicola J Goodson; Daniel H Solomon; Tianxi Cai; Katherine P Liao
Journal:  Rheumatology (Oxford)       Date:  2020-05-01       Impact factor: 7.580

2.  Vedolizumab Therapy Is Associated with an Improvement in Sleep Quality and Mood in Inflammatory Bowel Diseases.

Authors:  Betsy W Stevens; Nynke Z Borren; Gabriella Velonias; Grace Conway; Thom Cleland; Elizabeth Andrews; Hamed Khalili; John G Garber; Ramnik J Xavier; Vijay Yajnik; Ashwin N Ananthakrishnan
Journal:  Dig Dis Sci       Date:  2016-10-28       Impact factor: 3.199

Review 3.  Patient Electronic Health Records as a Means to Approach Genetic Research in Gastroenterology.

Authors:  Ashwin N Ananthakrishnan; David Lieberman
Journal:  Gastroenterology       Date:  2015-06-12       Impact factor: 22.682

Review 4.  Inflammatory Bowel Disease: Influence and Implications in Reproduction.

Authors:  Louise E Glover; Blair Fennimore; Mary Wingfield
Journal:  Inflamm Bowel Dis       Date:  2016-11       Impact factor: 5.325

5.  Genetic risk factors for serious infections in inflammatory bowel diseases.

Authors:  Saranya Sasidharan; Vijay Yajnik; Hamed Khalili; John Garber; Ramnik Xavier; Ashwin N Ananthakrishnan
Journal:  Scand J Gastroenterol       Date:  2017-02-05       Impact factor: 2.423

6.  High-throughput phenotyping with electronic medical record data using a common semi-supervised approach (PheCAP).

Authors:  Yichi Zhang; Tianrun Cai; Sheng Yu; Kelly Cho; Chuan Hong; Jiehuan Sun; Jie Huang; Yuk-Lam Ho; Ashwin N Ananthakrishnan; Zongqi Xia; Stanley Y Shaw; Vivian Gainer; Victor Castro; Nicholas Link; Jacqueline Honerlaw; Sicong Huang; David Gagnon; Elizabeth W Karlson; Robert M Plenge; Peter Szolovits; Guergana Savova; Susanne Churchill; Christopher O'Donnell; Shawn N Murphy; J Michael Gaziano; Isaac Kohane; Tianxi Cai; Katherine P Liao
Journal:  Nat Protoc       Date:  2019-11-20       Impact factor: 13.491

7.  Differences in Clinical Course, Genetics, and the Microbiome Between Familial and Sporadic Inflammatory Bowel Diseases.

Authors:  Nienke Z Borren; Grace Conway; John J Garber; Hamed Khalili; Shrish Budree; Himel Mallick; Vijay Yajnik; Ramnik J Xavier; Ashwin N Ananthakrishnan
Journal:  J Crohns Colitis       Date:  2018-04-27       Impact factor: 9.071

8.  A novel susceptibility locus in MST1 and gene-gene interaction network for Crohn's disease in the Chinese population.

Authors:  William K K Wu; Rui Sun; Tao Zuo; Yuanyuan Tian; Zhirong Zeng; Jeffery Ho; Justin C Y Wu; Francis K L Chan; Matthew T V Chan; Jun Yu; Joseph J Y Sung; Sunny H Wong; Maggie H Wang; Siew C Ng
Journal:  J Cell Mol Med       Date:  2018-02-14       Impact factor: 5.310

Review 9.  The Role of Vitamin D in Inflammatory Bowel Disease: Mechanism to Management.

Authors:  Jane Fletcher; Sheldon C Cooper; Subrata Ghosh; Martin Hewison
Journal:  Nutrients       Date:  2019-05-07       Impact factor: 5.717

Review 10.  Pleiotropic Effects of Vitamin D in Patients with Inflammatory Bowel Diseases.

Authors:  Aleksandra Szymczak-Tomczak; Alicja Ewa Ratajczak; Marta Kaczmarek-Ryś; Szymon Hryhorowicz; Anna Maria Rychter; Agnieszka Zawada; Ryszard Słomski; Agnieszka Dobrowolska; Iwona Krela-Kaźmierczak
Journal:  J Clin Med       Date:  2022-09-27       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.